Clinical investigation of heavy ion therapy system using scanning irradiatio
Phase 1
- Conditions
- Malignant tumor
- Registration Number
- JPRN-UMIN000005225
- Lead Sponsor
- ational Institute of Radiological Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 15
Inclusion Criteria
Not provided
Exclusion Criteria
1)Previous irradiation to the same site of the tumor 2)Expected prognosis within 6 months 3)Performance status more than or equal to 2 4)Active infection at the same site of the tumor 5)Other medical reasons for exclusion
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Acute radiation toxicity
- Secondary Outcome Measures
Name Time Method PET/CT imaging of autoactivation due to heavy particle irradiation Initial response of treated lesion
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie heavy ion therapy efficacy in malignant tumor treatment?
How does carbon ion scanning irradiation compare to photon therapy in Phase I oncology trials?
Which biomarkers correlate with response to heavy ion therapy in solid tumor patients?
What are the acute and late adverse events reported in JPRN-UMIN000005225 heavy ion trials?
Are there combination strategies with proton therapy or radiosensitizers for heavy ion systems?